We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Postmarket surveillance of natural health products in Canada: clinical and federal regulatory perspectives.
- Authors
Murty, Mano
- Abstract
Postmarket surveillance, particularly adverse reactions (ARs), forms an integral part of the ongoing safety evaluation for natural health products (NHPs). ARs can be related to many factors, including inherent toxicity, misuse, hypersensitivity, NHP–drug interactions, or product quality. High consumer use and limited safety and efficacy data from human clinical trials for many NHPs present a challenge to consumers, healthcare practitioners, and federal regulators. Canada’s Natural Health Products Regulations mandate NHPs to be licensed. As the currently available unauthorized NHPs are being brought into compliance in Canada, the transition has produced some challenges, requiring ongoing public communication and education to promote the safe use of NHPs. This article will highlight Health Canada’s key postmarket initiatives in strengthening the regulation of NHPs.
- Subjects
CANADA; DRUG side effects; HEALTH products; MEDICAL supplies; PRODUCT quality
- Publication
Canadian Journal of Physiology & Pharmacology, 2007, Vol 85, Issue 9, p952
- ISSN
0008-4212
- Publication type
Article
- DOI
10.1139/Y07-085